Bosnia and Herzegovina vs Finland: Tuberculosis treatment success rate in new and relapsed cases
Bosnia and Herzegovina
37
in 2023
Finland
34
in 2023
Bosnia and Herzegovina rank
197th
Finland rank
199th
Tuberculosis treatment success rate in new and relapsed cases over time
- Bosnia and Herzegovina
- Finland
How they compare
Bosnia and Herzegovina currently reports 37 against 34 in Finland, a difference of 3.
That makes Bosnia and Herzegovina's figure about 1.1 times Finland's.
The two have swapped places 2 times across 17 shared years of data; in 2007 it was Bosnia and Herzegovina ahead.
Bosnia and Herzegovina ranks 197th and Finland ranks 199th of 206 countries.
Bosnia and Herzegovina has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Finland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 95 | 40.67 | 54.33 | Bosnia and Herzegovina |
| 2010s | 63.9 | 39.1 | 24.8 | Bosnia and Herzegovina |
| 2020s | 45.25 | 16.75 | 28.5 | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate in new and relapsed cases, Bosnia and Herzegovina or Finland?
- Bosnia and Herzegovina, at 37 against 34 in Finland as of 2023.
- What is the difference in tuberculosis treatment success rate in new and relapsed cases between Bosnia and Herzegovina and Finland?
- 3, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Finland?
- 17 years are reported by both, from 2007 to 2023.
- How do Bosnia and Herzegovina and Finland rank globally for tuberculosis treatment success rate in new and relapsed cases?
- Bosnia and Herzegovina ranks 197th and Finland ranks 199th of 206 countries.
- Where does this data come from?
- Our World in Data, published as Tuberculosis treatment success rate in new and relapsed cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.